- Home
- FOXF vs FTRE Comparison
FOXF vs FTRE Comparison
Compare FOXF & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOXF
- FTRE
- Stock Information
- Founded
- FOXF 2007
- FTRE 1996
- Country
- FOXF United States
- FTRE United States
- Employees
- FOXF N/A
- FTRE N/A
- Industry
- FOXF Motor Vehicles
- FTRE Medical Specialities
- Sector
- FOXF Consumer Discretionary
- FTRE Health Care
- Exchange
- FOXF Nasdaq
- FTRE Nasdaq
- Market Cap
- FOXF 924.2M
- FTRE 864.4M
- IPO Year
- FOXF N/A
- FTRE N/A
- Fundamental
- Price
- FOXF $15.22
- FTRE $11.72
- Analyst Decision
- FOXF Strong Buy
- FTRE Hold
- Analyst Count
- FOXF 5
- FTRE 9
- Target Price
- FOXF $33.00
- FTRE $13.31
- AVG Volume (30 Days)
- FOXF 809.3K
- FTRE 1.2M
- Earning Date
- FOXF 11-06-2025
- FTRE 11-05-2025
- Dividend Yield
- FOXF N/A
- FTRE N/A
- EPS Growth
- FOXF N/A
- FTRE N/A
- EPS
- FOXF N/A
- FTRE N/A
- Revenue
- FOXF $1,459,086,000.00
- FTRE $2,759,900,000.00
- Revenue This Year
- FOXF $8.61
- FTRE $0.47
- Revenue Next Year
- FOXF $5.55
- FTRE N/A
- P/E Ratio
- FOXF N/A
- FTRE N/A
- Revenue Growth
- FOXF 6.22
- FTRE 1.88
- 52 Week Low
- FOXF $14.93
- FTRE $3.97
- 52 Week High
- FOXF $35.15
- FTRE $25.28
- Technical
- Relative Strength Index (RSI)
- FOXF 19.10
- FTRE 60.54
- Support Level
- FOXF $21.40
- FTRE $10.34
- Resistance Level
- FOXF $23.07
- FTRE $12.77
- Average True Range (ATR)
- FOXF 1.01
- FTRE 0.92
- MACD
- FOXF -0.76
- FTRE 0.08
- Stochastic Oscillator
- FOXF 0.19
- FTRE 69.69
About FOXF Fox Factory Holding Corp.
Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World.
About FTRE Fortrea Holdings Inc.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.